Gene ID ▲ | Gene Name | Gene Symbol | Disease Ontology |
---|---|---|---|
105998373 | ALG3 alpha-1,3- mannosyltransferase |
|
|
105998376 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
|
105998464 | polypeptide N-acetylgalactosaminyltransferase 17 |
|
|
105998569 | beta-1,4-N-acetyl-galactosaminyltransferase 4 |
|
|
105998632 | transmembrane O-mannosyltransferase targeting cadherins 1 |
|
|
105998696 | putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase |
|
|
105998808 | beta-1,3-glucuronyltransferase 2 |
|
|
105998840 | exostosin like glycosyltransferase 1 |
|
|
105998871 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
|
|
105999623 | ST6 beta-galactoside alpha-2,6-sialyltransferase 2 |
|
|
105999709 | ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
|
|
105999747 | ALG11 alpha-1,2-mannosyltransferase |
|
|
105999788 | polypeptide N-acetylgalactosaminyltransferase 10 |
|
|
105999846 | beta-1,3-galactosyltransferase 4 |
|
|
105999963 | probable C-mannosyltransferase DPY19L2 |
|
|
105999984 | dpy-19 like C-mannosyltransferase 1 |
|
|
106000059 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
|
|
106000225 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
|
106000554 | putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 |
|
|
106000598 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
|
|
106000600 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
|
|
106000899 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
|
|
106001289 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
|
|
106001296 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
|
|
106001905 | alpha-1,4-N-acetylglucosaminyltransferase |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024